The “Digital Pathology: Roadmap to the Future of Medical Diagnosis” report has been added to ResearchAndMarkets offering.
“Digital Pathology: Roadmap to the Future of Medical Diagnosis”
According to numerous research and surveys conducted across the world, the request for pathology services are increasing by a healthy percentage year-on-year which can be attributed to the increase in cancer prevalence across the globe, ageing population amongst a number of other factors.
Factoring in to the above the number of experienced pathologists available at the moment and ones about to retire, the scenario for pathology services may start to look grim. Therefore, an urgent solution is needed to tackle the challenges pertaining increase in diagnosis of patients and unreasonable timelines that pathologists are facing currently with the traditional pathology methods.
Proper deployment of Digital Pathology solutions have the demonstrated ability to streamline the workflow of pathology services, and can potentially increase the efficiency of the workflow and decrease the time for diagnosis.
The use of AI in digital pathology has gained momentum over the last few years. Notably, the FDA approved an AI-tool as a primary diagnosis tool as recently as in 2017 for wrist fractures.
Read More: Interview with Cédric Carbone, CTO at Ogury
The application of AI for pathology services are innumerable considering the fact the pathological services give rise to a lot of information.
Information or data sets that can serve as the basis of creating deep learning digital pathology tools that can act as a diagnosis supplement tool for pathologists, thus increasing the speed of diagnosis, maybe accuracy and certainly providing the potential to prioritize diagnosis cases based on severity for the pathologists to review.
The next decade of the medical field is set to witness the transformation of digital pathology services by AI tools.
- Optimal use of Big Data Key for AI Advancement in Digital Pathology
- Generation of Datasets for Validation Paramount to Overcome Regulatory Hurdles
- Transitioning from Pharmaceutical Industry Application to Mainstream Clinical Applications
1. Executive Summary
2. Workflow and Commercial Landscape of Digital Pathology
3. Segment Assessment – Cloud Technology
4. Segment Assessment – Whole Slide Imaging
5. Segment Assessment – Image Analysis
6. Segment Assessment – Artificial Intelligence
7. Case Study – Takeaways from Digital Pathology Adoption in a Medical Institute
8. Drivers and Challenges
9. Industry Landscape of Selected Companies
10. Patent Landscape Assessment
11. Growth Opportunities